OAKLAND, Calif., Aug. 8, 2019 /PRNewswire/ -- An effort to improve the scheduled cesarean section delivery experience found that changes to preoperative and postoperative processes can lead to reductions in opioid use without increased pain and with faster recovery, according to research from Kaiser Permanente published in the journal Obstetrics & Gynecology.

LOS ANGELES, Aug. 8, 2019 /PRNewswire/ -- "Speak Life," "Share Life," and "Take Flight," are some of the positive messages on a new colorful mural painted by South Los Angeles at-risk middle school and high school students and community artist Moses Ball.

SAN FRANCISCO, Aug. 8, 2019 /PRNewswire/ --  Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the second quarter ended June 30, 2019.Cash and investments in marketable securities at June 30, 2019 were $1.8 billion as compared to

SAN DIEGO, Aug. 8, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage Precision Cancer Medicine™ company, developing drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers, today announced company highlights and financial results for the second quarter ended

ROCKVILLE, Md., Aug. 8, 2019 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the

REDWOOD CITY, Calif., Aug. 8, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today reported financial results for the second quarter ended June 30, 2019. Revenue for the second quarter of 2019 was

LA JOLLA, Calif., Aug. 8, 2019 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of inno

TUCSON, Ariz., Aug. 8, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that Jack Phillips has been appointed Chief Operating Officer.  Mr. Phillips joins Accelerate from Roche Diagnostics, the world's leading diagnostics company.

PALO ALTO, Calif., Aug. 8, 2019 /PRNewswire/ -- This afternoon, Varian (NYSE: VAR) posted a presentation providing an overview of the recently proposed radiation oncology alternative payment model and calendar year 2020 rates by the Center for Medicare & Medicaid Services.  To access the web deck, visit the Investor Relations page on the Varian website at

SEATTLE and VANCOUVER, British Columbia, Aug. 8, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today provided an update on the cytisinicline clinical development program and anno